F-group (family)
2003.1.5.65 DOT1
Ligands and drugs
117
Member domains
64
with ligand contacts (≤ 4 Å)
54.7% of members
60
with DrugDomain annotations
51.3% of members
37
with a DrugBank compound
31.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.5.65 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00118 | SAM | Ademetionine | 11 |
| DB01752 | SAH | S-adenosyl-L-homocysteine | 8 |
| DB00640 | ADN | Adenosine | 2 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB04604 | 5ID | 5-iodotubercidin | 1 |
| DB12920 | EP6 | Pinometostat | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SAM | S-ADENOSYLMETHIONINE | 12 |
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 11 |
| UNX | UNKNOWN ATOM OR ION | 7 |
| Kmetal | POTASSIUM ION | 6 |
| 5JJ | N~6~-(2,6-dichlorophenyl)-N~6~-(pent-2-yn-1-yl)quinoline-4,6-diamine | 4 |
| 0QK | 7-{5-[(3-{[(4-tert-butylphenyl)carbamoyl]amino}propyl)(propan-2-yl)amino]-5-deoxy-beta-D-ribofuranosyl}-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 3 |
| CAmetal | CALCIUM ION | 3 |
| 5EG | 2-({5-[(2-chlorophenoxy)methyl]-1H-tetrazol-1-yl}acetyl)-N-(4-chlorophenyl)hydrazinecarboxamide | 2 |
| 5EK | N-[1-(2-chlorophenyl)-1H-indol-6-yl]-2-{[5-(2-chlorophenyl)-1H-tetrazol-1-yl]acetyl}hydrazinecarboxamide | 2 |
| 5EV | N~4~-methyl-N~2~-[2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl]pyrimidine-2,4-diamine | 2 |
| 5EW | 6'-chloro-1,4-dimethyl-5'-(2-methyl-6-{[4-(methylamino)pyrimidin-2-yl]amino}-1H-indol-1-yl)-3,3'-bipyridin-2(1H)-one | 2 |
| 5F4 | 4-(2,6-dichlorobenzoyl)-N-methyl-1H-pyrrole-2-carboxamide | 2 |
| 5F6 | (2,6-dichlorophenyl)(quinolin-6-yl)methanone | 2 |
| 5F7 | N-(2,6-dichlorophenyl)-4-methoxy-N-methylquinolin-6-amine | 2 |
| 5JT | (3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine | 2 |
| 5JU | N~2~-{[2-chloro-3-(2-methylpyridin-3-yl)-1-benzothiophen-5-yl]carbamoyl}-N-(3-{methyl[(3R)-1-(5H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]amino}propyl)glycinamide | 2 |
| ADN | ADENOSINE | 2 |
| N4W | ~{N}1-[(~{S})-(3-chlorophenyl)-pyridin-2-yl-methyl]-4-methylsulfonyl-~{N}2-pyrimidin-2-yl-benzene-1,2-diamine | 2 |
| N4Z | ~{N}1-[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]-~{N}2-(4-methoxy-6-piperazin-1-yl-1,3,5-triazin-2-yl)-4-methylsulfonyl-benzene-1,2-diamine | 2 |
| N5K | 3-[(4-azanyl-6-methoxy-1,3,5-triazin-2-yl)amino]-4-[[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]amino]benzenesulfonamide | 2 |